Rezolute Inc Share Price Today: Live Updates & Key Insights

Rezolute Inc share price today is $2.5, up 0.81%. The stock opened at $2.44 against the previous close of $2.47, with an intraday high of $2.49 and low of $2.365.

Rezolute Inc Share Price Chart

Rezolute Inc

us-stock
To Invest in {{usstockname}}
us-stock

Rezolute Inc Share Price Performance

$2.5 0.0081(0.81%) RZLT at 23 Mar 2026 03:06 PM Biotechnology
Lowest Today 2.365
Highest Today 2.49
Today’s Open 2.44
Prev. Close 2.47
52 Week High 11.46
52 Week Low 1.07
Day’s Range: Low 2.365 High 2.49
52-Week Range: Low 1.07 High 11.46
1 day return -
1 Week return +0.8
1 month return -22.18
3 month return +21.76
6 month return -69.39
1 year return -18.36
3 year return +21.76
5 year return -68.63
10 year return -

Rezolute Inc Institutional Holdings

Federated Hermes Inc 14.67

RA Capital Management, LLC 9.59

Federated Hermes Kaufmann R 8.88

Federated Hermes Kaufmann Growth 7.82

Opaleye Management Inc 6.57

Federated Hermes Kaufmann Small Cap A 6.46

BlackRock Inc 5.23

Vanguard Group Inc 5.00

Federated Hermes Kaufmann Small Cap Grow 4.97

Balyasny Asset Management LLC 4.71

Blackstone Inc 3.16

Mangrove Partners 3.01

UBS Group AG 2.82

Vanguard Total Stock Mkt Idx Inv 2.59

Great Point Partners LLC 2.56

Affinity Asset Advisors, LLC 2.46

State Street® SPDR® S&P® Biotech ETF 2.42

FMR Inc 2.41

State Street Corp 2.19

Integral Health Asset Management, LLC 2.09

Fidelity Advisor Biotechnology I 2.07

Geode Capital Management, LLC 2.04

iShares Russell 2000 ETF 2.01

Millennium Management LLC 1.79

Vestal Point Capital LP 1.76

Jane Street Group LLC 1.47

Bank of America Corp 1.34

Point72 Asset Management, L.P. 1.21

Vanguard Institutional Extnd Mkt Idx Tr 0.92

Fidelity Small Cap Index 0.82

State St Russell Sm/Mid Cp® Indx SL Cl I 0.62

iShares Russell 2000 Growth ETF 0.60

Fidelity Extended Market Index 0.46

Schwab US Small-Cap ETF™ 0.44

Vanguard Russell 2000 ETF 0.40

Kennedy Micro Cap 0.38

Fidelity Advisor Small Cap I 0.29

State St Russell Sm Cap® Indx SL Cl I 0.28

Vanguard Strategic Small-Cap Equity Inv 0.27

BNY Mellon Sm/Md Cp Gr I 0.24

Rezolute Inc Market Status

Strong Buy: 7

Buy: 3

Hold: 0

Sell: 0

Strong Sell: 0

Rezolute Inc Fundamentals

Market Cap 238.29 M

PB Ratio 1.8467

PE Ratio 0.0

Enterprise Value 104.72 M

Total Assets 175.49 M

Volume 8710928

Rezolute Inc Company Financials

Annual Revenue FY25:0 0.0M, FY24:0 0.0M, FY23:0 0.0M, FY22:0 0.0M, FY21:0 0.0M

Annual Profit FY25:-31000 -0.0M, FY24:-36000 -0.0M, FY23:null 0.0M, FY22:null 0.0M, FY21:null 0.0M

Annual Net worth FY25:-74412000 -74.4M, FY24:-68459000 -68.5M, FY23:-51787000 -51.8M, FY22:-38781000 -38.8M, FY21:-21277000 -21.3M

Quarterly Revenue Q4/2025:0 0.0M, Q3/2025:0 0.0M, Q2/2025:46000 0.0M, Q1/2025:0 0.0M, Q4/2024:0 0.0M

Quarterly Profit Q4/2025:-7000 -0.0M, Q3/2025:-8000 -0.0M, Q2/2025:-8000 -0.0M, Q1/2025:-7000 -0.0M, Q4/2024:null 0.0M

Quarterly Net worth Q4/2025:-22774000 -22.8M, Q3/2025:-18150000 -18.2M, Q2/2025:-24390000 -24.4M, Q1/2025:-18914000 -18.9M, Q4/2024:-15730000 -15.7M

About Rezolute Inc & investment objective

Company Information Rezolute, Inc., a late-stage rare disease company, focused on improving outcomes for individuals with hypoglycemia caused by hyperinsulinism in the United States. Its lead clinical asset is ersodetug, an intravenously administered human monoclonal antibody that is in Phase 3 clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder, as well as for the treatment of hypoglycemia; and clinical trials of ersodetug for tumor hyperinsulinism. The company was formerly known as AntriaBio, Inc. and changed its name to Rezolute, Inc. in December 2017. Rezolute, Inc. was founded in 2010 and is headquartered in Redwood City, California.

Organisation Biotechnology

Employees 75

Industry Biotechnology

CEO Mr. Nevan Charles Elam J.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Rezolute Inc FAQs

What is the share price of Rezolute Inc today?

The current share price of Rezolute Inc is $2.5.

Can I buy Rezolute Inc shares in India?

Yes, Indian investors can buy Rezolute Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Rezolute Inc shares in India?

You can easily invest in Rezolute Inc shares from India by:

Can I buy fractional shares of Rezolute Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Rezolute Inc?

Rezolute Inc has a market cap of $238.29 M.

In which sector does Rezolute Inc belong?

Rezolute Inc operates in the Biotechnology sector.

What documents are required to invest in Rezolute Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Rezolute Inc?

The PE ratio of Rezolute Inc is N/A and the PB ratio is 1.85.